Better treatments for some of cancer's deadliest forms could be closer due to a University of California, Irvine-led discovery about how a certain protein is activated in tumor cells. The finding, spearheaded by researchers ...
Cell & Microbiology
Jul 18, 2022
0
73
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor ...
Bio & Medicine
Sep 20, 2011
0
0
Pancreatic cancer is one of the deadliest types of cancers in humans. It is the fourth leading cause of cancer-related deaths in the western world. The early stages of the disease often progress without symptoms, so diagnosis ...
Bio & Medicine
Nov 15, 2023
0
3
One of the most frustrating problems faced by doctors who treat pancreatic cancer is the lack of effective therapeutic options. More than 38,000 people in the United States die of the disease each year, and new drugs and ...
Biochemistry
Nov 5, 2010
0
0
(Phys.org)—The medical community is armed with new insights and new options for drug design and discovery to treat fatal diseases such as pancreatic cancer. Using in silico computational tools to complement the results ...
Bio & Medicine
Oct 10, 2012
0
0
The research team led by Prof. Yang Lihua from Hefei National Laboratory for Physical Sciences at the Microscale, School of Chemistry and Materials Science of the University of Science and Technology of China (USTC) of the ...
Bio & Medicine
Mar 18, 2021
0
12
Nanoparticles, or tiny molecules that can deliver a payload of drug treatments and other agents, show great promise for treating cancers. Scientists can build them in various shapes with different materials, often as porous, ...
Bio & Medicine
Oct 27, 2022
0
55
A group lead by Prof. Horacio Cabral (Visiting Scientist of iCONM/Associate Professor of Bioengineering, Graduate School of Engineering, University of Tokyo) has discovered a new approach for the treatment of triple-negative ...
Bio & Medicine
Dec 6, 2022
0
30
Pancreatic cancer is an exceedingly malignant tumor in the digestive system, and its five-year survival rate is little more than 10%. Metabolic alterations are one of the hallmarks of tumor cells. Oncogenic Kras-activated ...
Biochemistry
Aug 19, 2022
0
82
PARP inhibitors are recently developed drugs that have shown great promise against some types of ovarian, breast, prostate and pancreatic cancer, but many patients' tumors develop resistance to the drugs. Now researchers ...
Cell & Microbiology
Jan 19, 2021
0
24
